A Study of LY3841136 in Healthy and Overweight Participants

NCT05295940 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Healthy

Interventions

DRUG: LY3841136
DRUG: Placebo

Sponsor

Eli Lilly and Company